Brokerages predict that Cooper Companies Inc (NYSE:COO) will announce earnings per share (EPS) of $2.96 for the current quarter, Zacks reports. Ten analysts have made estimates for Cooper Companies’ earnings, with estimates ranging from $2.92 to $3.03. Cooper Companies reported earnings per share of $2.65 in the same quarter last year, which suggests a positive year-over-year growth rate of 11.7%. The firm is expected to announce its next earnings report after the market closes on Thursday, December 6th.

According to Zacks, analysts expect that Cooper Companies will report full year earnings of $11.61 per share for the current fiscal year, with EPS estimates ranging from $11.56 to $11.68. For the next year, analysts anticipate that the business will post earnings of $12.12 per share, with EPS estimates ranging from $11.78 to $12.72. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that cover Cooper Companies.

COO has been the topic of a number of research reports. Wells Fargo & Co upped their target price on Cooper Companies from $290.00 to $295.00 and gave the stock an “outperform” rating in a research report on Monday, November 12th. Zacks Investment Research downgraded Cooper Companies from a “hold” rating to a “sell” rating in a research note on Monday, September 3rd. BMO Capital Markets upped their price objective on Cooper Companies from $280.00 to $285.00 and gave the company an “outperform” rating in a research note on Friday, August 31st. Raymond James increased their price target on Cooper Companies from $270.00 to $300.00 and gave the stock an “outperform” rating in a research note on Friday, September 21st. Finally, Oppenheimer set a $270.00 price target on Cooper Companies and gave the stock a “hold” rating in a research note on Friday, August 31st. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $276.22.

In related news, VP Randal Golden sold 1,731 shares of the business’s stock in a transaction dated Thursday, September 27th. The stock was sold at an average price of $275.86, for a total value of $477,513.66. Following the sale, the vice president now directly owns 1,154 shares in the company, valued at $318,342.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Allan E. Rubenstein sold 1,500 shares of the business’s stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $265.37, for a total value of $398,055.00. Following the completion of the sale, the director now owns 3,068 shares in the company, valued at $814,155.16. The disclosure for this sale can be found here. Insiders have sold 20,691 shares of company stock valued at $5,527,869 in the last three months. 1.60% of the stock is currently owned by corporate insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in Cooper Companies by 0.6% during the 3rd quarter. Vanguard Group Inc. now owns 5,041,468 shares of the medical device company’s stock valued at $1,397,243,000 after acquiring an additional 31,280 shares in the last quarter. Janus Henderson Group PLC raised its stake in shares of Cooper Companies by 23.8% during the 2nd quarter. Janus Henderson Group PLC now owns 2,618,690 shares of the medical device company’s stock valued at $616,595,000 after buying an additional 502,783 shares during the last quarter. Frontier Capital Management Co. LLC raised its stake in shares of Cooper Companies by 13.5% during the 3rd quarter. Frontier Capital Management Co. LLC now owns 937,389 shares of the medical device company’s stock valued at $259,797,000 after buying an additional 111,828 shares during the last quarter. FIL Ltd grew its position in shares of Cooper Companies by 16.1% during the 3rd quarter. FIL Ltd now owns 815,901 shares of the medical device company’s stock valued at $226,127,000 after acquiring an additional 113,054 shares during the period. Finally, Bessemer Group Inc. grew its position in shares of Cooper Companies by 0.8% during the 3rd quarter. Bessemer Group Inc. now owns 761,555 shares of the medical device company’s stock valued at $211,064,000 after acquiring an additional 5,828 shares during the period.

COO traded up $2.28 during trading on Friday, hitting $277.18. The company’s stock had a trading volume of 37,754 shares, compared to its average volume of 324,903. Cooper Companies has a twelve month low of $216.47 and a twelve month high of $283.18. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.54 and a current ratio of 2.58. The firm has a market cap of $13.51 billion, a PE ratio of 28.56, a price-to-earnings-growth ratio of 2.10 and a beta of 0.77.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Read More: What are different types of coverage ratios?

Get a free copy of the Zacks research report on Cooper Companies (COO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.